An Algorithm as a Biomarker for Response to Immune Checkpoint Inhibitor Therapy

被引：1
|
作者：
Rimm, David L. [1 ]
机构：
[1] Yale Univ, Dept Pathol & Med Oncol, Sch Med, New Haven, CT USA
来源：
JAMA ONCOLOGY | 2023年 / 9卷 / 01期
关键词：
D O I：
10.1001/jamaoncol.2022.4772
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [21] Retrospective analysis of digital biomarker predictability of immune checkpoint inhibitor therapy outcomes in patients with NSCLC
    Abousaud, Marin
    Frame, David
    Harvey, R. Donald
    Kaddoura, Layan
    Ekpenyong, Asari
    Abousaud, Aseala
    Steuer, Conor Ernst
    Derstine, Brian
    Wang, Nicholas C.
    Mackler, Emily R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer
    Naqash, Abdul Rafeh
    Kihn-Alarcon, Alba J.
    Stavraka, Chara
    Kerrigan, Kathleen
    Vareki, Saman Maleki
    Pinato, David James
    Puri, Sonam
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [23] Gut microbiotas and immune checkpoint inhibitor therapy response: a causal or coincidental relationship?
    Janket, Sok-Ja
    Ackerson, Leland K.
    Diamandis, Eleftherios P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (01) : 18 - 24
  • [24] NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy
    Danilov, K.
    Bansal, D.
    Ward, C.
    Al-Obaidi, A.
    Pluard, T.
    Tarasov, A.
    Valiev, I.
    Kushnarev, V.
    Makarova, A.
    Butusova, A.
    Love, A.
    Nomie, K.
    Bagaev, A.
    Subramanian, J.
    Fowler, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S241 - S241
  • [25] Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy
    Loosen, Sven H.
    van den Bosch, Vincent
    Gorgulho, Joao
    Schulze-Hagen, Maximilian
    Kandler, Jennis
    Joerdens, Markus S.
    Tacke, Frank
    Loberg, Christina
    Antoch, Gerald
    Bruemmendorf, Tim
    Neumann, Ulf P.
    Kuhl, Christiane
    Luedde, Tom
    Roderburg, Christoph
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [26] The prognostic role of lymphocyte count for treatment response in immune checkpoint inhibitor therapy
    Conroy, M.
    O'Sullivan, H.
    Collins, D.
    Bambury, R.
    Power, D. G.
    Grossman, S.
    O'Reilly, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S289 - S289
  • [27] Biomarker Trends in Patients With Immune-Checkpoint Inhibitor Myocarditis
    Vasbinder, Alexi
    Chen, YeeAnn
    Gradone, Allison
    Azam, Tariq
    Perry, Daniel
    Shadid, Husam
    Anderson, Elizabeth
    Catalan, Tonimarie
    Blakely, Pennelope
    Adie, Sarah
    Pogue, Kristen
    Leja, Monika
    Yentz, Sarah
    Schneider, Bryan
    Fecher, Leslie
    Lao, Christopher D.
    Hayek, Salim
    CIRCULATION, 2022, 146
  • [28] EMERGING COMPLICATION OF IMMUNE CHECKPOINT INHIBITOR THERAPY
    Buntak, Vesna
    Loutoo, Ariane J.
    Joseph, Phillip
    CHEST, 2023, 164 (04) : 3177A - 3177A
  • [29] Tissue biomarkers of immune checkpoint inhibitor therapy
    Davoudi, Fatemeh
    Moradi, Afshin
    Sadeghirad, Habib
    Kulasinghe, Arutha
    IMMUNOLOGY AND CELL BIOLOGY, 2024, 102 (03): : 179 - 193
  • [30] Immune checkpoint inhibitor therapy for hepatocellular carcinoma
    Ramai, Daryl
    Shapiro, Alexandra
    Facciorusso, Antonio
    Bareggi, Claudia
    Gambini, Donatella
    Rijavec, Erika
    Tomasello, Gianluca
    Galassi, Barbara
    Ghidini, Michele
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (06): : 568 - 576
12345